Trial assesses the impact of two immunomodulators in reducing CV risk among rheumatoid arthritis patients


People with rheumatoid arthritis are at increased risk of cardiovascular (CV) disease, with studies indicating an approximate 50 percent increase in risk of CV events such as heart attack and stroke.

Care home nurses still need support to recover from COVID trauma, research shows

Previous article

Laos malaria outbreak in 2020–21 likely caused by multidrug-resistant strains of P. falciparum

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News